Categories: News

CENTR Continues to Expand Retail Availability Across the U.S.

Vancouver, British Columbia–(Newsfile Corp. – January 6, 2022) – CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the “Company“), one of North America’s leading functional beverage companies, today announced that, as of the end of November, CENTR and CENTR Sugar Free are sold in approximately 1,800 retail locations across the United States.

“2021 was a breakthrough year for distribution of CENTR and CENTR Sugar Free,” said Company CEO Joseph Meehan. “Working with our national distributor and regional partners, we expect 2022 to demonstrate even stronger retail penetration for our family of the country’s leading CBD products. CENTR products are on track for even more explosive account growth in 2022, with early numbers suggesting the Company will double or triple the prior years retail account penetration. We plan on providing updates to the Company’s retail account growth each month going forward. Together with our upcoming launch of CENTR’s online store, we will provide ever-growing opportunities to Find Your CENTR.”

About CENTR Brands Corp.

CENTR Brands Corp. is one of North America’s leading functional beverage companies. CENTR develops and markets non-alcoholic, functional ingestibles for the global market. The Company produces CENTR and CENTR Sugar Free, both sparkling, low calorie, CBD beverages as well as CENTR Instant, a family of on-the-go CBD powders. For more information visit www.findyourcentr.com, and follow on Instagram at @findyourcentr.

For further information, contact Joseph Meehan at jmeehan@centrcorp.com.

On behalf of the Board,

CENTR BRANDS CORP.

/s/ Joseph Meehan
Joseph Meehan, Chairman & Chief Executive Officer

This press release may contain “Forward-Looking Statements” within the meaning of applicable Canadian securities laws. Actual results may differ from those indicated as a result of finalization of the Company’s financial statements as well as other risks and uncertainties. Such statements represent the Company’s current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Many factors, both known and unknown, could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affecting such statements and information other than as required by applicable laws, rules and regulations.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/109225

Staff

Recent Posts

SeaStar Medical Holding Corporation Investors: Robbins LLP Reminds Shareholders of the SeaStar Medical Holding Corporation (ICU) Class Action

SAN DIEGO--(BUSINESS WIRE)--$ICU #ICU--Robbins LLP reminds investors that a shareholder filed a class action on…

3 hours ago

Glaukos to Release Second Quarter 2024 Financial Results after Market Close on July 31

Conference Call and Webcast Scheduled for 1:30 p.m. PTALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS),…

3 hours ago

Eligo Publishes in Nature a Landmark Study That Unlocks Genome Editing of Bacteria in the Gut

PARIS, July 10, 2024 /PRNewswire/ -- For the first time, a team of scientists at Eligo…

3 hours ago

Building telehealth equity: Insights from the Sault Ste. Marie Tribe of Chippewa Indians

New study identifies five recommendations for improving health care equity SAULT STE. MARIE, Mich., July 10, 2024…

3 hours ago

Glytec Announces Major Deals and Continued Market Leadership in Diabetes Care

Glytec Adds New Wins in 1H 2024 to Drive Inpatient Diabetes Market Momentum and Leadership…

3 hours ago

EnsoData expands sleep apnea screening and diagnosis capabilities with new acquisition

New acoustic flow and microphone channels will allow EnsoData to improve access and affordability in…

3 hours ago